Skip Ribbon Commands
Skip to main content

Our people

Current Responsibilities
Mr. Cunningham is an Executive Vice President located in JLL’s New Jersey office market brokerage group.  He provides corporate representation for both the acquisition and disposition of commercial real estate and manages strategic planning and site development activities for his clients, with expertise in the pharmaceutical and biotech industries.  Mr. Cunningham is also a member of JLL’s Life Sciences Practice.

Mr. Cunningham began his career at JLL in February 2017.

Prior to joining JLL, Mr. Cunningham was National Director of the Life Sciences Practice at Colliers International, representing pharmaceutical, biotech and medical device companies in the Tri-State region, nationally and internationally. Mr. Cunningham was also responsible for coordination of business development and transacting acquisition and disposition assignments for Practice Group Clients.

Client Representation  

  • Ashland Inc.
  • Impax Laboratories
  • Teva Pharmaceuticals
  • Amarin Pharma
  • J&J
  • Pfizer
  • Industrial Realty Group
  • Sanofi

Education and Affiliations
Mr. Cunningham is a graduate of Wittenberg University, Springfield, Ohio. 

Mr. Cunningham is a member of the Board of Trustees of The Midland School, a private nonprofit special education school for children with developmental disabilities in North Branch, New Jersey. For over fifty years, Midland has provided quality programs and activities to enable our students to reach their highest level of achievement and independence, and to become contributing members of their communities.

Mr. Cunningham is also a member of the New Jersey Biotechnology Council.